Atomera Earnings Calls
| Release date | May 05, 2026 |
| EPS estimate | -$0.133 |
| EPS actual | -$0.170 |
| EPS Surprise | -28.21% |
| Revenue estimate | 75K |
| Revenue actual | 11K |
| Revenue Surprise | -85.33% |
| Release date | Feb 12, 2026 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.140 |
| Revenue estimate | 100K |
| Revenue actual | 50K |
| Revenue Surprise | -50.00% |
| Release date | Oct 28, 2025 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.170 |
| EPS Surprise | -21.43% |
| Revenue estimate | 100K |
| Revenue actual | 11K |
| Revenue Surprise | -89.00% |
| Release date | Aug 05, 2025 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.170 |
| EPS Surprise | -21.43% |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Atomera
Below you can see how ATOM performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 05, 2025 |
| Price on release | $4.66 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.170 |
| EPS surprise | -21.43% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $5.03 |
| Jul 31, 2025 | $5.00 |
| Aug 01, 2025 | $4.66 |
| Aug 04, 2025 | $4.57 |
| Aug 05, 2025 | $4.66 |
| Aug 06, 2025 | $3.60 |
| Aug 07, 2025 | $3.83 |
| Aug 08, 2025 | $3.52 |
| Aug 11, 2025 | $3.60 |
| 4 days before | -7.36% |
| 4 days after | -22.75% |
| On release day | -22.85% |
| Change in period | -28.43% |
| Release date | Oct 28, 2025 |
| Price on release | $3.25 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.170 |
| EPS surprise | -21.43% |
| Date | Price |
|---|---|
| Oct 22, 2025 | $2.87 |
| Oct 23, 2025 | $3.23 |
| Oct 24, 2025 | $3.15 |
| Oct 27, 2025 | $3.30 |
| Oct 28, 2025 | $3.25 |
| Oct 29, 2025 | $3.17 |
| Oct 30, 2025 | $3.01 |
| Oct 31, 2025 | $3.16 |
| Nov 03, 2025 | $2.87 |
| 4 days before | 13.44% |
| 4 days after | -11.69% |
| On release day | -2.46% |
| Change in period | 0.175% |
| Release date | Feb 12, 2026 |
| Price on release | $2.39 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.140 |
| Date | Price |
|---|---|
| Feb 06, 2026 | $2.57 |
| Feb 09, 2026 | $2.52 |
| Feb 10, 2026 | $2.46 |
| Feb 11, 2026 | $2.46 |
| Feb 12, 2026 | $2.39 |
| Feb 13, 2026 | $3.92 |
| Feb 17, 2026 | $5.73 |
| Feb 18, 2026 | $5.48 |
| Feb 19, 2026 | $6.66 |
| 4 days before | -7.00% |
| 4 days after | 178.66% |
| On release day | 64.02% |
| Change in period | 159.14% |
| Release date | May 05, 2026 |
| Price on release | $10.56 |
| EPS estimate | -$0.133 |
| EPS actual | -$0.170 |
| EPS surprise | -28.21% |
| Date | Price |
|---|---|
| Apr 29, 2026 | $7.25 |
| Apr 30, 2026 | $8.18 |
| May 01, 2026 | $11.09 |
| May 04, 2026 | $10.37 |
| May 05, 2026 | $10.56 |
| May 06, 2026 | $9.13 |
| May 07, 2026 | $8.10 |
| May 08, 2026 | $8.41 |
| May 11, 2026 | $8.28 |
| 4 days before | 45.66% |
| 4 days after | -21.59% |
| On release day | -13.54% |
| Change in period | 14.21% |
Atomera Earnings Call Transcript Summary of Q1 2026
Atomera reported progress across multiple high-value markets in Q1 2026, with technical and commercial momentum highlighted in advanced logic (gate-all-around), memory, RF SOI, power devices, and GaN on silicon. The company has measured silicon results for MST in gate-all-around structures (generated in partnership with a strategic tool vendor) that outperform alternative dopant-diffusion control approaches, and is running demonstrations with two target gate-all-around customers (expected multi-month cycles including customer fab runs). Momentum in memory engagements continues but lags logic. In GaN on silicon, Atomera disclosed preliminary data indicating MST can dramatically reduce the parasitic sheet charge at the GaN/Si interface—potentially a major RF and power advantage—and is validating this with partners and targeting both 200 mm and 300 mm workflows. Strategic relationships (tool partner, Synopsys, universities and national labs) are deepening to accelerate validation and customer adoption. Financially, Q1 GAAP net loss was $6.1M ($0.17/share) and non-GAAP net loss $4.9M ($0.14/share). Cash and equivalents rose to $41.1M after a $25M registered direct offering plus ATM proceeds; the company reiterated full-year 2026 non-GAAP OpEx guidance of ~$18.5M. Near-term revenue remains minimal (Q1 revenue $11k; Q2 expected $50k–$100k), and Atomera is focused on converting technical validation into commercial, royalty-bearing agreements.
Sign In
Buy ATOM